Business Description

NAYA Biosciences
NAICS : 339112
SIC : 3841
ISIN : US44984F1049
Description
NAYA Biosciences operates a healthcare services fertility business as well as expand its focus to the development of first-in-class clinical-stage assets in oncology and autoimmune diseases.
Financial Strength
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.18 | |||||
Equity-to-Asset | 0.08 | |||||
Debt-to-Equity | 3.94 | |||||
Debt-to-EBITDA | -1 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | -5.83 | |||||
Beneish M-Score | 1.18 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -20.1 | |||||
3-Year EBITDA Growth Rate | 39.6 | |||||
3-Year EPS without NRI Growth Rate | 45.2 | |||||
3-Year FCF Growth Rate | 42.8 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 45.77 | |||||
9-Day RSI | 50.03 | |||||
14-Day RSI | 51.45 | |||||
6-1 Month Momentum % | -27.55 | |||||
12-1 Month Momentum % | -45.38 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.3 | |||||
Quick Ratio | 0.27 | |||||
Cash Ratio | 0.12 | |||||
Days Inventory | 30.19 | |||||
Days Sales Outstanding | 9.7 | |||||
Days Payable | 239.72 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -72.9 | |||||
Shareholder Yield % | -222.09 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 44.89 | |||||
Operating Margin % | -90.87 | |||||
Net Margin % | -122.79 | |||||
FCF Margin % | -65.58 | |||||
ROE % | -3788.77 | |||||
ROA % | -42.5 | |||||
ROIC % | -26.67 | |||||
3-Year ROIIC % | -5.51 | |||||
ROC (Joel Greenblatt) % | -120.92 | |||||
ROCE % | -61.15 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 0.4 | |||||
EV-to-EBIT | -2.55 | |||||
EV-to-EBITDA | -2.84 | |||||
EV-to-Revenue | 2.64 | |||||
EV-to-Forward-Revenue | 0.68 | |||||
EV-to-FCF | -4.02 | |||||
Earnings Yield (Greenblatt) % | -39.22 | |||||
FCF Yield % | -113.23 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:NAYA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
NAYA Biosciences Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 5.77 | ||
EPS (TTM) ($) | -2.54 | ||
Beta | 2.87 | ||
Volatility % | 94.03 | ||
14-Day RSI | 51.45 | ||
14-Day ATR ($) | 0.124794 | ||
20-Day SMA ($) | 0.826147 | ||
12-1 Month Momentum % | -45.38 | ||
52-Week Range ($) | 0.63 - 3.5 | ||
Shares Outstanding (Mil) | 3.91 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
NAYA Biosciences Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
NAYA Biosciences Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
NAYA Biosciences Frequently Asked Questions
What is NAYA Biosciences(NAYA)'s stock price today?
The current price of NAYA is $0.85. The 52 week high of NAYA is $3.50 and 52 week low is $0.63.
When is next earnings date of NAYA Biosciences(NAYA)?
The next earnings date of NAYA Biosciences(NAYA) is 2024-11-13 Est..
Does NAYA Biosciences(NAYA) pay dividends? If so, how much?
NAYA Biosciences(NAYA) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |